The importance of safeguarding NHS patients
Catherine Chmiel, Safeguarding Lead for R&I sets out to raise awareness that safeguarding in everybody's business and discusses how and why it is important to report concerning behaviour.
Read moreResearch and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
Genetic test could give women a more accurate breast cancer risk when combined with standard screening
New research shows a promising genetic test, when combined with mammograms, could provide a more accurate breast cancer risk in women attending routine breast cancer screening
Read more
MRC Confidence in Concept (CiC) 2018 launch event and networking lunch
Part of the MRC translational research strategy and provides annual awards of £250k-£1.2m to be used flexibly to support the earliest stages of multiple translational research projects.
Read more
Mould discovery in lungs paves way for helping hard to treat asthma
A team at The University of Manchester have found that the standard treatment for asthma - oral steroids - was associated with increased levels of the treatable mould Aspergillus in the lung.
Read more
Funding Available for Haelo’s 2018-19 Improvement Science for Leaders programme
MAHSC Inflammation & Repair and Cardiovascular Domains is funding the programme fees for two project teams on Haelo’s 2018-19 Improvement Science for Leaders programme
Read more
Disease discoveries unlock door to diagnosis and new treatments
An international team of scientists and doctors has identified a family of five new genetic diseases which are likely to affect more than 1 in 5000 children.
Read more
Thank you to everyone who supported our research during 2017
We'd like to say a massive thank you to everyone who participated in, delivered or supported research at Manchester University NHS Foundation Trust during 2017.
Read more
2017 First Patient Challenge
At the start of 2017 teams were challenged to pursue as many first patients recruited to commercially sponsored trials as they could, whether first global, European or UK. Find out how well they did!
Read more
